Micra无导线起搏器的临床应用进展
Advances in Clinical Application of Micra Leadless Pacemaker
DOI: 10.12677/acm.2024.1482210, PDF,    科研立项经费支持
作者: 戴慧苗：西安医学院研究生院，陕西 西安；空军军医大学唐都医院心血管内科，陕西 西安；李栋栋, 高春城, 刘 浩, 韩 靖, 郭万刚*：空军军医大学唐都医院心血管内科，陕西 西安
关键词: 无导线起搏器；传统经静脉起搏器；并发症；生活质量；与多种起搏方式的联合应用；Leadless Pacemaker； Traditional Transvenous Pacemaker； Complications； Quality of Life； Combined Application with Various Pacing Modes
摘要: 无导线起搏器作为缓慢性心律失常治疗领域的新星，已经在临床试验中得到了广泛关注与研究。其中，Micra是目前国内唯一使用的无导线心脏起搏器，其应用消除了与传统经静脉起搏导线和皮下囊袋相关并发症，减少了锁骨下静脉穿刺可能引发的血胸、气胸等相关并发症，但其使用存在较高的心包积液/穿孔风险。对于高危及特殊人群，无导线起搏器同样展现出了其可行性和安全性。此外，与传统的经静脉起搏器相比，亦显著提升患者的生活质量。本文结合近年来的相关研究报道，现就无导线心脏起搏器的技术进展、安全性和有效性研究、优势、与多种起搏方式的联合应用、挑战与展望等方面做一综述。
Abstract: As a rising star in the field of bradycardia treatment, leadless pacemakers have attracted significant attention and been tested in clinical trials. Among the leadless pacemakers, Micra is currently the only one used domestically. Its application eliminated complications associated with traditional transvenous pacing leads and subcutaneous pockets, and reduced the risk of hemothorax, pneumothorax, and other related complications that may be caused by subclavian vein puncture. However, there is a higher risk of pericardial effusion/perforation in the application of Micra. For high-risk and special patient populations, leadless pacemakers have also showed demonstrable feasibility and safety. Moreover, compared with traditional transvenous pacemaker, leadless pacemakers significantly improve patients’ quality of life. This article combines relevant research reports in recent years to provide a comprehensive review of the technological advancements, safety and effectiveness studies, advantages, combined applications with various pacing methods, challenges, and the future of leadless cardiac pacemakers.
文章引用：戴慧苗, 李栋栋, 高春城, 刘浩, 韩靖, 郭万刚. Micra无导线起搏器的临床应用进展[J]. 临床医学进展, 2024, 14(8): 264-270. https://doi.org/10.12677/acm.2024.1482210

参考文献

[1] Mulpuru, S.K., Madhavan, M., McLeod, C.J., Cha, Y. and Friedman, P.A. (2017) Cardiac Pacemakers: Function, Troubleshooting, and Management. Journal of the American College of Cardiology, 69, 189-210. [Google Scholar] [CrossRef] [PubMed]
[2] Michowitz, Y., Kronborg, M.B., Glikson, M. and Nielsen, J.C. (2021) The ‘10 Commandments’ for the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. European Heart Journal, 42, 4295-4295. [Google Scholar] [CrossRef] [PubMed]
[3] 钟洁敏, 张幼聪. 永久心脏起搏器植入常见并发症临床分析[J]. 中西医结合心血管病电子杂志, 2018, 6(3): 55, 58.
[4] Chaudhry, U., Borgquist, R., Smith, J.G. and Mörtsell, D. (2022) Efficacy of the Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infection in a High-Risk Population. EP Europace, 24, 1973-1980. [Google Scholar] [CrossRef] [PubMed]
[5] Kirkfeldt, R.E., Johansen, J.B., Nohr, E.A., Jorgensen, O.D. and Nielsen, J.C. (2013) Complications after Cardiac Implantable Electronic Device Implantations: An Analysis of a Complete, Nationwide Cohort in Denmark. European Heart Journal, 35, 1186-1194. [Google Scholar] [CrossRef] [PubMed]
[6] Piccini, J.P., El-Chami, M., Wherry, K., Crossley, G.H., Kowal, R.C., Stromberg, K., et al. (2021) Contemporaneous Comparison of Outcomes among Patients Implanted with a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. JAMA Cardiology, 6, 1187-1195. [Google Scholar] [CrossRef] [PubMed]
[7] El-Chami, M.F., Bockstedt, L., Longacre, C., Higuera, L., Stromberg, K., Crossley, G., et al. (2021) Leadless vs. Transvenous Single-Chamber Ventricular Pacing in the Micra CED Study: 2-Year Follow-Up. European Heart Journal, 43, 1207-1215. [Google Scholar] [CrossRef] [PubMed]
[8] Spickler, J.W., Rasor, N.S., Kezdi, P., Misra, S.N., Robins, K.E. and LeBoeuf, C. (1970) Totally Self-Contained Intracardiac Pacemaker. Journal of Electrocardiology, 3, 325-331. [Google Scholar] [CrossRef] [PubMed]
[9] Reddy, V.Y., Exner, D.V., Cantillon, D.J., Doshi, R., Bunch, T.J., Tomassoni, G.F., et al. (2015) Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. New England Journal of Medicine, 373, 1125-1135. [Google Scholar] [CrossRef] [PubMed]
[10] Lakkireddy, D., Knops, R., Atwater, B., Neuzil, P., Ip, J., Gonzalez, E., et al. (2017) A Worldwide Experience of the Management of Battery Failures and Chronic Device Retrieval of the Nanostim Leadless Pacemaker. Heart Rhythm, 14, 1756-1763. [Google Scholar] [CrossRef] [PubMed]
[11] Darlington, D., Brown, P., Carvalho, V., Bourne, H., Mayer, J., Jones, N., et al. (2022) Efficacy and Safety of Leadless Pacemaker: A Systematic Review, Pooled Analysis and Meta-analysis. Indian Pacing and Electrophysiology Journal, 22, 77-86. [Google Scholar] [CrossRef] [PubMed]
[12] Soejima, K., Edmonson, J., Ellingson, M.L., Herberg, B., Wiklund, C. and Zhao, J. (2016) Safety Evaluation of a Leadless Transcatheter Pacemaker for Magnetic Resonance Imaging Use. Heart Rhythm, 13, 2056-2063. [Google Scholar] [CrossRef] [PubMed]
[13] Cabanas‐Grandío, P., García Campo, E., Bisbal, F., García‐Seara, J., Pachón, M., Juan‐Salvadores, P., et al. (2019) Quality of Life of Patients Undergoing Conventional vs Leadless Pacemaker Implantation: A Multicenter Observational Study. Journal of Cardiovascular Electrophysiology, 31, 330-336. [Google Scholar] [CrossRef] [PubMed]
[14] Chinitz, L., Ritter, P., Khelae, S.K., Iacopino, S., Garweg, C., Grazia-Bongiorni, M., et al. (2018) Accelerometer-Based Atrioventricular Synchronous Pacing with a Ventricular Leadless Pacemaker: Results from the Micra Atrioventricular Feasibility Studies. Heart Rhythm, 15, 1363-1371. [Google Scholar] [CrossRef] [PubMed]
[15] Steinwender, C., Khelae, S.K., Garweg, C., Chan, J.Y.S., Ritter, P., Johansen, J.B., et al. (2020) Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results from the MARVEL 2 Study. JACC: Clinical Electrophysiology, 6, 94-106. [Google Scholar] [CrossRef] [PubMed]
[16] Escalante, K. (2023) Micra AV2 and Micra VR2 Longevity Comparison. Medtronic Data on File.
[17] Reynolds, D.W. and Ritter, P. (2016) A Leadless Intracardiac Transcatheter Pacing System. The New England Journal of Medicine, 374, 2604-2605.
[18] Roberts, P.R., Clementy, N., Al Samadi, F., Garweg, C., Martinez-Sande, J.L., Iacopino, S., et al. (2017) A Leadless Pacemaker in the Real-World Setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm, 14, 1375-1379. [Google Scholar] [CrossRef] [PubMed]
[19] 中国医师协会心律学专业委员会, 中华医学会心电生理和起搏分会. 无导线起搏器临床应用中国专家共识(2022) [J]. 中华心律失常学杂志, 2022, 26(3): 263-271.
[20] Mitacchione, G., Schiavone, M., Gasperetti, A., Viecca, M., Curnis, A. and Forleo, G.B. (2021) Atrioventricular Synchronous Leadless Pacemaker: State of Art and Broadened Indications. Reviews in Cardiovascular Medicine, 22, 395-401. [Google Scholar] [CrossRef] [PubMed]
[21] 汤宝鹏﹐张澍, 黄德嘉. 无导线心脏起搏器, 未来可期[J]. 中华心律失常学杂志, 2021, 25(1): 5-9.
[22] Steinwender, C., Lercher, P., Schukro, C., Blessberger, H., Prenner, G., Andreas, M., et al. (2019) State of the Art: Leadless Ventricular Pacing: A National Expert Consensus of the Austrian Society of Cardiology. Journal of Interventional Cardiac Electrophysiology, 57, 27-37. [Google Scholar] [CrossRef] [PubMed]
[23] 牟秦娇, 张玥, 王楠. 无导线起搏器在特殊人群中植入的研究进展[J]. 心血管病学进展, 2023, 44(8): 694-698, 703.
[24] Birnie, D.H., Wang, J., Alings, M., Philippon, F., Parkash, R., Manlucu, J., et al. (2019) Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. Journal of the American College of Cardiology, 74, 2845-2854. [Google Scholar] [CrossRef] [PubMed]
[25] El‐Chami, M.F., Johansen, J.B., Zaidi, A., Faerestrand, S., Reynolds, D., Garcia‐Seara, J., et al. (2019) Leadless Pacemaker Implant in Patients with Pre‐existing Infections: Results from the Micra Postapproval Registry. Journal of Cardiovascular Electrophysiology, 30, 569-574. [Google Scholar] [CrossRef] [PubMed]
[26] Lu, X., Zhang, H., Gu, T., Bai, X., Zhan, Y., Feng, H., et al. (2022) Study on the Effect of Cardiac Pacemaker Implantation on the Psychological Status of Young and Middle-Aged Patients. Minerva Surgery, 77, 618-620. [Google Scholar] [CrossRef] [PubMed]
[27] Yu, M., Li, Y.P., Shi, D.M. and Zhou, Y.J. (2022) Comparation of Quality of Life in Chinese Patients Undergoing Leadless versus Conventional Pacemaker Implantation. Clinical Cardiology, 46, 49-56. [Google Scholar] [CrossRef] [PubMed]
[28] Palmisano, P., Guido, A., Panico, V., Chiuri, M.D., Chiarillo, M.V., Sergi, C., et al. (2021) Leadless Pacemaker versus Transvenous Single-Chamber Pacemaker Therapy: Peri-Procedural Aspects, Utilization of Medical Resources and Patient Acceptance. Expert Review of Medical Devices, 18, 483-491. [Google Scholar] [CrossRef] [PubMed]
[29] Adduci, C., Palano, F., Silvetti, G., Cosentino, P. and Francia, P. (2020) Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator. High Blood Pressure & Cardiovascular Prevention, 27, 291-297. [Google Scholar] [CrossRef] [PubMed]
[30] Ljungström, E., Brandt, J., Mörtsell, D., Borgquist, R. and Wang, L. (2019) Combination of a Leadless Pacemaker and Subcutaneous Defibrillator with Nine Effective Shock Treatments during Follow-Up of 18 Months. Journal of Electrocardiology, 56, 1-3. [Google Scholar] [CrossRef] [PubMed]
[31] Ng, J.B., Chua, K. and Teo, W.S. (2018) Simultaneous Leadless Pacemaker and Subcutaneous Implantable Cardioverter‐Defibrillator Implantation—When Vascular Options Have Run Out. Journal of Arrhythmia, 35, 136-138. [Google Scholar] [CrossRef] [PubMed]
[32] Montemerlo, E., Pozzi, M., De Ceglia, S., Santini, F., Piazzi, E. and Rovaris, G. (2019) First‐in‐Man Fully Leadless Transvenous CRT‐P with a Transseptal Implant of WISE‐CRT® System and Micra® Pm. Pacing and Clinical Electrophysiology, 42, 1489-1492. [Google Scholar] [CrossRef] [PubMed]
[33] Carabelli, A., Jabeur, M., Jacon, P., Rinaldi, C.A., Leclercq, C., Rovaris, G., et al. (2020) European Experience with a First Totally Leadless Cardiac Resynchronization Therapy Pacemaker System. EP Europace, 23, 740-747. [Google Scholar] [CrossRef] [PubMed]
[34] Piccini, J.P., Cunnane, R., Steffel, J., El-Chami, M.F., Reynolds, D., Roberts, P.R., et al. (2022) Development and Validation of a Risk Score for Predicting Pericardial Effusion in Patients Undergoing Leadless Pacemaker Implantation: Experience with the Micra Transcatheter Pacemaker. EP Europace, 24, 1119-1126. [Google Scholar] [CrossRef] [PubMed]

为你推荐